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hnRNP A/B proteins modulate the alternative splicing of several mammalian and viral pre-mRNAs, and are typically
viewed as proteins that enforce the activity of splicing silencers. Here we show that intronic hnRNP A/B–binding sites
(ABS) can stimulate the in vitro splicing of pre-mRNAs containing artificially enlarged introns. Stimulation of in vitro
splicing could also be obtained by providing intronic ABS in trans through the use of antisense oligonucleotides
containing a non-hybridizing ABS-carrying tail. ABS-tailed oligonucleotides also improved the in vivo inclusion of an
alternative exon flanked by an enlarged intron. Notably, binding sites for hnRNP F/H proteins (FBS) replicate the
activity of ABS by improving the splicing of an enlarged intron and by modulating 59 splice-site selection. One
hypothesis formulated to explain these effects is that bound hnRNP proteins self-interact to bring in closer proximity
the external pair of splice sites. Consistent with this model, positioning FBS or ABS at both ends of an intron was
required to stimulate splicing of some pre-mRNAs. In addition, a computational analysis of the configuration of
putative FBS and ABS located at the ends of introns supports the view that these motifs have evolved to support
cooperative interactions. Our results document a positive role for the hnRNP A/B and hnRNP F/H proteins in generic
splicing, and suggest that these proteins may modulate the conformation of mammalian pre-mRNAs.
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splicing. PLoS Biol 4(2): e21.
Introduction
Exons represent approximately 1% of the human genome
and range in size from 1 to 1,000 nucleotides (nt), with a mean
size for internal exons of 145 nt [1]. In contrast, introns
constitute 24% of our genome, with sizes ranging from 60 to
more than 200,000 nt. The mean size of human introns is more
than 3,300 nt, and nearly 20% of human introns are larger
than 5 kb [1]. While the efﬁcient and accurate removal of
introns is crucial for the production of functional mRNAs, it
remains unclear as to how an intron is deﬁned when splicing
junctions are separated by thousands of nucleotides. Although
intron size can inﬂuence alternative splicing in mammals [2],
the mechanisms that enforce the removal of large mammalian
introns have not been investigated—partly because introns
larger than 1 kb are not spliced efﬁciently in vitro.
Some of the decisions associated with the removal of large
introns are likely to be similar to the choices made by the
splicing machinery when selecting alternative splice sites.
Choosing the appropriate pair of splice sites in alternative
splicing units requires the contribution of many types of
elements that are recognized by different classes of proteins,
including serine/arginine–residue proteins (SR) and hnRNP
proteins. hnRNP A1 was the ﬁrst protein of its class to be
attributed a function in splice-site selection based on its
ability to antagonize the activity of the SR protein ASF/SF2 in
an in vitro 59 splice-site selection assay [3]. hnRNP A/B
proteins have now been documented to modulate the
alternative splicing of many mammalian and viral pre-
mRNAs (for a review, see [4]). In one case, an exonic binding
site for hnRNP A1 prevents the interaction of positively-
acting SR proteins by a process that apparently involves the
nucleation of several A1 molecules [5]. Our previous work on
the alternative splicing of the hnRNP A1 pre-mRNA led to a
different model to explain the activity of hnRNP A/B proteins
bound to intronic sites. In this case, bound hnRNP A/B
proteins would self-interact to loop out and repress internal
splice sites [4,6,7]. This postulated change in pre-mRNA
conformation would bring in closer proximity the external
pair of exons, an event that may also enforce intron
deﬁnition. Notably, putative binding sites for hnRNP A/B
are more abundant in introns than in exons (1.2 sites and 0.35
sites per 1,000 nt, respectively), and are found more
frequently near splice junctions [6].
A similar bias in the distribution of GGG motifs has been
observed in mammalian introns [8–16]. GGG motifs located
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PLoS BIOLOGYdownstream from a 59 splice site facilitate intron deﬁnition
[13,17–19], and their insertion near the 59 splice site of a Fugu
intron stimulates splicing in a mammalian cell line [15].
Because many binding sites for hnRNP A/B and F/H proteins
contain G triples [20–23], hnRNP A/B and hnRNP F/H
proteins bound near the ends of an intron may be responsible
for the activity of GGG motifs and, hence, may play a generic
role in intron deﬁnition.
We examined the role of hnRNP A/B and hnRNP F/H
proteins in intron removal by making use of the observation
that enlarged introns are spliced poorly in vitro. We show
that cis- and trans-acting binding sites for hnRNP A/B and
hnRNP F/H proteins (ABS and FBS, respectively) stimulate
the splicing of such introns. For some pre-mRNAs, the
splicing-enhancing activity of ABS or FBS requires that these
sites be positioned at both ends of the intron, consistent with
the view that hnRNP A/B and F/H proteins act cooperatively
to change pre-mRNA conformation. Overall, our results
suggest that hnRNP A/B and hnRNP F/H proteins may
stimulate splicing by facilitating intron deﬁnition.
Results
Binding Sites for hnRNP A/B Proteins Stimulate the In
Vitro Splicing of Enlarged Introns
To monitor splicing activity, we ﬁrst used model pre-
mRNAs with small introns that are spliced efﬁciently in vitro
(7-Ad and 7B-Ad; Figure 1A) [7]. As determined by the RT-
PCR ampliﬁcation of the resulting mRNA products, a time-
course co-incubation of these two pre-mRNAs in a HeLa
nuclear extract indicates that they are spliced with similar
efﬁciencies (Figure 1B, lanes 1–6). Insertion of a 1,015-nt
lambda fragment in the intron of each model substrate
generated the 7-AdA( . ) and 7B-AdA( . ) derivatives. These
larger pre-mRNAs were spliced less efﬁciently than the small-
intron versions (Figure 1B, lanes 7–12 and accompanying
graph). A splicing efﬁciency inferior to 1% was estimated by
visualizing labeled lariat molecules in a conventional splicing
gel (Figure 1C, lane 2). Different lambda inserts of similar
lengths had a similar effect on splicing, as seen when the 7-
AdB( . ) and 7-AdC( . ) pre-mRNAs were co-incubated in
splicing mixtures with the small-intron 7B-Ad pre-mRNA
(Figure 1D, lanes 2–6). Thus, increasing intron size with a
variety of lambda inserts reduced in vitro splicing efﬁciency.
To determine whether hnRNP A/B proteins could stimulate
the splicing of these enlarged introns, an ABS corresponding
to the CE1a element in the mouse hnRNP A1 pre-mRNA
[6,24] was inserted at two positions in the enlarged introns:
one ABS was inserted 26 nt downstream from the 59 splice
junction, while the second ABS was inserted 88 nt upstream
from the 39 splice junction (Figure 1A). The presence of two
ABS in the 7-AdA(a.a) and 7B-AdA(a.a) pre-mRNAs stimu-
lated splicing approximately 4-fold (Figure 1B, lanes 13–18
and accompanying graph). Likewise, when lariat splicing
products were detected in a conventional splicing gel using
32P-labeled transcripts, the presence of ABS stimulated in
vitro splicing 3-fold (Figure 1C, lane 4). Splicing stimulation
was also observed when ABS were inserted in the 7-AdB and
7-AdC pre-mRNAs (Figure 1D, lanes 7–11). Stimulation was
estimated to be in the order of 3- to 5-fold, based on
ampliﬁcation reactions performed in the presence of
32P-
dCTP (data not shown). Replacing ABS with 20-nt inverted
repeats also stimulated large-intron splicing (Figure 1D, lanes
12–16), suggesting that looping out intron sequences can
improve the in vitro splicing efﬁciency of enlarged introns.
We also tested the impact of ABS on the splicing of large-
intron pre-mRNAs carrying the 39 splice site of Bcl-x exon 3
(7-BclA and 7B-BclA). The presence of ABS also stimulated
the production of amplicons corresponding to mRNA
products (Figure 1E; compare the intensities of the 7/Bcl
and 7B/Bcl products in lanes 2–6 with those in lanes 7–11).
To ensure equivalent recovery and loading of the various
samples in future experiments, we relied on systematically co-
incubating each test pre-mRNA with a control small-intron
pre-mRNA in splicing mixtures. mRNA products derived
from both substrates could then be ampliﬁed simultaneously
by RT-PCR using the same primer set. In these conditions, we
conﬁrmed that the stimulation offered by ABS was observed
at different ratios of test and control pre-mRNAs (Figure S1).
To conﬁrm the participation of hnRNP A/B proteins in
splicing stimulation, we added to a HeLa nuclear extract
increasing amounts of a DNA oligonucleotide (TS10) carrying
high-afﬁnity binding sites for A1 and A2 (apparent Kd less
than 5 nM, data not shown and see [25,26]). We have shown
previously that an excess of TS10 abrogates the activity of
ABS in alternative splicing [6]. An excess of TS10 similarly
reduced the splicing efﬁciency of the 7-AdB(a.a) pre-mRNA,
without affecting the ampliﬁcation of splicing products
derived from the 7B-Ad small-intron pre-mRNA (Figure 2A,
lanes 6–10).
We also tested the impact of increasing the level of hnRNP
A1 in the extract by using recombinant A1 protein. GST-A1
stimulated the splicing efﬁciency of 7-AdB(a.a) (Figure 2B,
lanes 5–8). In contrast, splicing of the control small-intron
7B-Ad pre-mRNA was not affected by the addition of GST-
A1. GST-A1 also stimulated splicing of the 7-AdB( . ) pre-
mRNA in a dose-dependent manner (Figure 2B, lanes 1–4).
The reason for this stimulation is unclear. It is possible that
weaker ABS in the large intron of the 7-AdB pre-mRNA are
activated when the concentration of hnRNP A1 is increased.
In contrast, splicing of the large-intron pre-mRNA carrying
inverted repeats was not further stimulated by the addition of
GST-A1 (lanes 9–12). A His-tagged version of A1 (His-A1) was
as active as GST-A1 at stimulating large-intron splicing
(Figure 2C and 2D). In contrast, the addition of His-tagged
UP1 (His-UP1), a shortened version of A1 lacking the C-
terminal glycine-rich domain, did not stimulate splicing of
the large-intron pre-mRNAs (Figure 2D). Rather, His-UP1
slightly impaired splicing of the ABS-containing 7-AdA(a.a)
pre-mRNA, possibly because it antagonized the binding of
endogenous hnRNP A/B proteins.
We have recently used antisense oligonucleotides carrying
a non-hybridizing ABS-containing tail to alter splicing
decisions in vitro and in vivo [27]. The ABS tail interfered
with splicing when the antisense portion of the oligonucleo-
tide was complementary to exonic sequences upstream of 59
splice sites. To verify whether ABS-tailed oligonucleotides
could now act positively by reproducing the effect of cis-
acting ABS, we added to a HeLa extract a mixture of trans-
acting ABS-containing oligonucleotides complementary to
the ends of the introns in the 7-AdA( . ) and 7B-AdA( . )
pre-mRNAs (UA and Da; Figure 3A). The in vitro splicing of
these pre-mRNAs was stimulated in both cases (Figure 3B,
lanes 1–3 and lanes 9–12, respectively). The UA and Da
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hnRNP A/B and F/H Proteins Aid in SplicingFigure 1. Binding Sites for hnRNP A1/A2 Stimulate the In Vitro Removal of Enlarged Introns
(A) The model pre-mRNAs contain portions of exons 7 or 7B of the hnRNP A1 gene paired with the adenovirus L2 exon. The size of the small introns in
7-Ad and 7B-Ad pre-mRNAs is indicated in nt. The size of lambda inserts A, B, and C are, respectively, 1015, 943, and 1038 nt. The lambda inserts do not
contain the sequences UAGGG
U/A or UAGAG
U/A, which correspond to high-affinity binding sites for hnRNP A/B proteins [20,43]. The larger intron
substrates contain either exon 7 or exon 7B as first exon, and either the adenovirus L2 or the Bcl-x exon 3 as second exon. When no other elements are
inserted, the pre-mRNAs correspond to the ( . ) version. The (a.a) versions contain ABS inserted 26 nt downstream of the 59 splice site and 88 nt
upstream of the 39 splice site. The (!. ) versions contain inverted repeats at the same positions as ABS.
(B) The 7-Ad and 7B-Ad pre-mRNAs were co-incubated for the times indicated (in minutes) in a HeLa nuclear extract (lanes 1–6). Additional mixtures
were prepared with pre-mRNAs carrying lambda insert A lacking or containing ABS (lanes 7–12 and 13–18, respectively). The concentration of each pre-
mRNA was 80 pM. Following RNA extraction, the mRNA products from mixtures were amplified by RT-PCR using a common set of primers (reverse
primer complementary to the adenovirus exonic sequence and forward primer corresponding to plasmid sequence upstream of exon 7 or exon 7B
sequences). The graph displays the abundance of amplified splicing product at different times for 7-Ad and the different 7-AdA pre-mRNAs. The RT-PCR
assay shown here and in other figures was performed in conditions that displayed a linear relationship between the amounts of input RNA and
amplified products over a large range of input RNA concentrations (from 10-fold less to at least 6-fold more than the amounts used in the assays [data
not shown]).
(C) Splicing reactions were set using
32P-labeled pre-mRNAs and incubated for 0 or 2 h in HeLa nuclear extracts. Total RNA was extracted, and the
splicing products were fractionated on a 5% acrylamide/8 M urea gel. The position of the lariat products is indicated.
(D) Each of the 7-Ad pre-mRNAs carrying lambda inserts B or C (7-AdB or 7-AdC; 80 pM) was co-incubated with the small-intron 7B-Ad pre-mRNA (8 pM).
Versions lacking ( . ) or containing ABS (a.a), as well as carrying inverted repeats (!. ), were used. Following incubation for different times, spliced
products were amplified by RT-PCR using a common set of primers. The co-incubated small-intron control is only shown for the 7-AdC pre-mRNA
mixture. M indicates molecular-weight markers.
(E) Large-intron pre-mRNAs 7-BclA and 7B-BclA (80 pM each) lacking ( . ) or containing ABS (a.a) were co-incubated for the indicated times in a HeLa
extract. RT-PCR was performed as described in (B) except that a Bcl-x reverse primer was used. The band amplified at t¼0 (lane 2) is artifactual and does
not co-migrate with the 7B/Bcl splicing product. M indicates molecular-weight markers.
DOI: 10.1371/journal.pbio.0040021.g001
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hnRNP A/B and F/H Proteins Aid in Splicingmixture also stimulated splicing of the 7-AdA(a.a) pre-mRNA
(Figure 3B, lanes 4–6). In contrast, the oligonucleotide
mixture did not improve splicing of a pre-mRNA carrying
the B insert (lanes 7 and 8). In general, concentrations of
oligonucleotides varying between 0.08 and 160 nM stimulated
splicing (representing a molar excess of 10- to 2,000-fold
relative to the pre-mRNA). The level of stimulation ranged
from 2- to 8-fold between different experiments (data not
shown). Concentrations superior to 160 nM usually promoted
a speciﬁc reduction in the splicing efﬁciency of enlarged
introns, possibly because of titration of hnRNP A/B proteins
by an excess of ABS-containing oligonucleotides (data not
shown).
Our results with the ABS-containing oligonucleotide
mixture therefore suggest that hnRNP A/B proteins can be
recruited at the intended positions in the intron. This
conclusion was supported by the results of an immunopre-
cipitation assay performed in nuclear extracts using an anti-
A1 antibody and a portion of the 7-AdA pre-mRNA. The
results show that recovery of the RNA is improved by the
presence of a cis-acting ABS (Figure 3C, compare lanes 3 and
4). Likewise, providing a trans-acting ABS as part of the tail of
an antisense oligonucleotide stimulates recovery (lane 6), a
result not observed when the oligonucleotide carries a non-
ABS tail (lane 5). Thus, a cis-o rtrans-acting ABS improves the
association of hnRNP A1 with the target RNA.
We have recently proposed that the mechanism underlying
the activity of hnRNP A/B proteins in alternative splicing
involves an interaction between bound A/B proteins such that
portions of the pre-mRNA are looped out, therefore
changing pre-mRNA structure to favor contacts between
the external pair of exons [6]. One prediction from this
model is that the presence of ABS at both ends of the
enlarged intron should be required to observe stimulation of
splicing. We used trans-acting ABS-containing oligonucleo-
tides to assess whether providing an ABS at either the
upstream or the downstream position could stimulate
splicing. First, we present the activity of individual trans-
acting ABS on a pre-mRNA carrying the 39 splice site of
human Bcl-x exon 3 (7B-BclA). The addition of oligonucleo-
tides UA and Db stimulated 7B/Bcl splicing (Figure 3D, lanes
1–6), a result that reproduced the activity of cis-acting ABS
Figure 2. The hnRNP A1 Protein Stimulates Large-Intron Splicing
(A) Sequestering hnRNP A/B proteins affects large-intron splicing. The large-intron substrates 7-AdB lacking ABS ( . ) or containing ABS (a.a) were co-
incubated with the small-intron 7B-Ad pre-mRNA (80 pM for the 7-AdB substrates and 16 pM for the control 7B-Ad pre-mRNA) in a HeLa extract for 90
min in the presence of increasing amounts of the telomeric oligonucleotide TS10 (0, 80, 160, 320, and 640 nM, respectively).
(B) Splicing mixtures were incubated with increasing amounts of recombinant GST-A1 protein (0, 0.8, 1.6, and 3.2 lM). The 7-AdB pre-mRNA carrying
inverted repeats (!. ) was also used.
(C) Splicing mixtures containing the 7-AdB and the small-intron 7B-Ad were supplemented with His-A1 and GST-A1 (0.5 lM each).
(D) The histogram depicts a compilation of three independent experiments performed with the indicated concentrations of recombinant proteins. In
each case, individual values obtained for the splicing of 7-AdA ( . ) or 7-AdA (a.a) pre-mRNAs were normalized with the splicing efficiency of the small
intron 7B-Ad pre-mRNA. Error bars indicate standard deviations.
DOI: 10.1371/journal.pbio.0040021.g002
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hnRNP A/B and F/H Proteins Aid in SplicingFigure 3. Antisense Oligonucleotides Carrying ABS Stimulate the Splicing of Large Introns
(A) Schematic representation of model large-intron pre-mRNAs and the position and structure of the RNA oligonucleotides. Oligonucleotides UA and UB
form a duplex with sequences located 46–65 and 46–64 nt, respectively, downstream from the 59 splice site. Oligonucleotides Db and Da, respectively,
hybridize 123–142 nt and 68–87 nt upstream of the 39 splice junction.
(B) The 7-AdA pre-mRNA lacking ABS ( . ) or containing ABS (a.a) was incubated in a HeLa extract in the absence (lanes 1 and 4) or in the presence
(lanes 2 and 3, and lanes 5 and 6) of UA and Da oligonucleotides (16 and 40 nM of each oligonucleotide). The 7-AdB pre-mRNA ( . ) and the 7B-AdA
pre-mRNAs were also incubated in the presence of UA and Da (40 nM in lane 8, and 0.08, 0.8, and 8 nM in lanes 10–12, respectively). As internal control
for splicing, a smaller quantity of the small-intron 7B-Ad pre-mRNA (lanes 1–8) or the small-intron 7-Ad pre-mRNA (lanes 9–12) was co-incubated with
the test substrates. Incubation in HeLa extracts was for 60 min.
(C) Labeled transcripts corresponding to the first 196 of the 7-AdA( . ) pre-mRNA (lanes 1, 4, 5, and 6) or the first 237 nt of the ABS-containing 7-
AdA(a.a) pre-mRNA (lanes 2 and 3) were incubated in a HeLa nuclear extract in the presence of 100 pM of the ABS-lacking UAn oligonucleotide (lane 5)
PLoS Biology | www.plosbiology.org February 2006 | Volume 4 | Issue 2 | e21 0176
hnRNP A/B and F/H Proteins Aid in Splicing(Figure 1E). Stimulation required the presence of both
oligonucleotides since UA or Db alone did not stimulate
splicing (Figure 3D, lanes 7 and 9).
Providing a non-hybridizing oligonucleotide with an ABS
tail was inactive (lane 8), and combining this oligonucleotide
with the non-hybridizing Da oligonucleotide also did not
provide stimulation (lane 10). Thus, stimulation of 7B-BclA
pre-mRNA splicing required a combination of upstream and
downstream trans-acting ABS, suggesting cooperative inter-
actions between these sites, in accord with the looping-out
model. Second, we tested the impact of individual oligonu-
cleotides on pre-mRNAs carrying the adenovirus 39 splice site
(7-AdA). Notably, the upstream UA oligonucleotide alone
stimulated 7-AdA splicing almost as efﬁciently as the UA and
Da mixture (Figure 3E, lanes 2 and 6). The UA oligonucleo-
tide alone also stimulated 7B-AdA splicing (lane 11). In
contrast, the downstream Da oligonucleotide alone did not
stimulate splicing (lane 5). Providing the ABS as a 39 rather
than a 59 extension was also stimulatory (UOA; Figure 3D,
lane 3), and no activity was provided by an oligonucleotide
carrying a non-ABS extension (UBn; lane 14), or an ABS-
containing oligonucleotide complementary to the ﬁrst exon
(UST; lane 9). A single cis-acting ABS at the upstream position
in the large intron of the 7-AdA also stimulated splicing (7-
AdA[a. ]; Figure 3F). Trans-acting ABS hybridizing at a
distance greater than 250 nt from the 59 splice site did not
signiﬁcantly enhance splicing (data not shown).
Likewise, placing two cis-acting ABS in the middle of an
enlarged intron did not stimulate splicing (data not shown).
Thus, while positioning an ABS relatively close to the 59 splice
siteisapparentlyimportantforsplicingstimulation,asinglecis-
ortrans-actingABSpositionednearthe59splicesiteissufﬁcient
for stimulating splicing of the 7-AdA and 7B-AdA pre-mRNAs.
Thisconclusioncontrastswiththeresultsobtainedwiththe7B-
BclA pre-mRNA and does not a priori support the looping-out
model.Althoughthereasonforthisdifferenceremainsunclear,
hnRNPA1hasbeenreportedtobindtotheadenovirus39splice
site [28]. Thus, a high-afﬁnity A1-binding site located at this
position may collaborate with an ABS near the 59 splice site to
stimulate pre-mRNA splicing. Unfortunately, we could not
conﬁrm this hypothesis experimentally because the putative
ABS directly overlaps the adenovirus 39 splice site, and
mutating the ABS would inhibit splicing.
Antisense Oligonucleotides Carrying ABS Stimulate
Splicing of an Enlarged Intron In Vivo
To address whether ABS can stimulate intron splicing in
vivo, we relied on a model pre-mRNA used previously to
demonstrate the negative inﬂuence of intron size on exon
inclusion [2]. The CD44 model pre-mRNA contains the V3
alternative exon ﬂanked downstream by an enlarged intron
containing six adjacent 977-nt spacer elements derived from
lambda DNA (Figure 4A). In this conﬁguration, the enlarged
intron promotes exon V3 skipping [2]. We tested the effect of
providing trans-acting ABS at one or both ends of the
enlarged intron. Following transfection of the CD44 plasmid
in COS-7 cells, a second transfection was performed with
antisense 29O-Me oligonucleotides carrying an ABS tail.
hnRNP A1 binds very well to 29O-Me RNA [27]. Compared
to a control oligonucleotide lacking an ABS tail (UV3NT;
Figure 4B), oligonucleotides complementary to the 59 end of
the intron and carrying only one ABS stimulated exon V3
inclusion very slightly (from 20% with UV3NT to 29% with
UV3A1 with a p-value of 0.1 based on three separate
experiments). A more important stimulation was obtained
when the tailed oligonucleotide carried two, three, or ﬁve
ABS (UV3A1W, UV3A1W3, and UV3A1W5, respectively,
promoting an average of 36%, 48%, and 73% inclusion). A
control oligonucleotide with ﬁve adjacent ABS but lacking a
portion complementary to the CD44 mini-gene did not
improve exon V3 inclusion (mA1W5). Exon inclusion was
also stimulated by tailed oligonucleotides complementary to
the 39 portion of the intron (D16A1 and D16A1W).
Providing oligonucleotides as mixtures (UV3A1/D16A1,
UV3A1W/D16A1W, UV3A1W3/D16A1W, or UV3A1W5/
D16A1W) offered little or no additional stimulation when
compared to the effect of providing the upstream oligonu-
cleotide alone. Consistent with our previous study [27], the
activity of the ABS-tailed oligonucleotides was compromised
when the concentration of hnRNP A1/A2 proteins was
reduced through the use of siRNAs targeting the A1/A2
mRNAs (data not shown). Thus, oligonucleotides designed to
deliver an ABS at the 59 or the 39 end of the intron stimulated
splicing of the enlarged intron in vivo. However, this
experiment did not reveal an apparent cooperation between
terminal ABS (see Discussion).
FBS Duplicate the In Vitro Modulating Activity of ABS
hnRNP F/H proteins have afﬁnity for G-stretches [23].
Thus, a subset of the GGG motifs found near the ends of
mammalian introns may be bound by hnRNP F/H proteins.
Moreover, hnRNP F/H proteins contain glycine-rich domains,
and similar domains promote an interaction between hnRNP
A1 proteins. For these reasons, we tested whether an FBS
could stimulate the in vitro splicing of an enlarged intron. We
used the hnRNP H-binding site identiﬁed in the cystathionine
b-synthase gene [29], a site that contains 2 G quadruples
(Figure 5A). The insertion of two copies of this FBS at the
upstream position in the intron of the 7-AdB pre-mRNA did
not stimulate in vitro splicing (Figure 5B, lanes 2 and 4).
Likewise, inserting one FBS at the downstream position of the
enlarged intron did not improve splicing efﬁciency (Figure
or the ABS-containing UA (lane 6). Mixtures were immunoprecipitated with an anti-hnRNP A1 antibody and resolved in a denaturing 5% polyacrylamide
gel. The initial input for each transcript representing 1/25th of the total amount is shown in lanes 1 and 2.
(D) The 7B-BclA was co-incubated with 100-fold less of the small-intron 7-Ad control pre-mRNA and increasing amounts of the UA and Db
oligonucleotide mixture (0, 0.08, 0.8, 8, 80, and 160 nM) or with 160 nM of individual or mixtures of various oligonucleotides.
(E) The 7-AdA pre-mRNA was co-incubated with the small-intron 7B-Ad pre-mRNA in a HeLa nuclear extract for 90 min at 30 8C. Each oligonucleotide was
used at a concentration of 160 nM. The 7-AdA(a.a) pre-mRNA containing cis-acting ABS elements was used as a control (lane 7). In lanes 8–11, the 7B-AdA
pre-mRNAwas co-incubated with the small-intron7-Ad pre-mRNA and 80 nM of oligonucleotides. In lanes 12–14, the 7-AdB pre-mRNAwas co-incubated
with the 7B-Ad control pre-mRNA and either the UB or UBn (40 nM each). UBn carries a non-ABS tail. Incubation was for 60 min in a HeLa extract.
(F) The control 7B-Ad pre-mRNA was co-incubated with 7-AdA pre-mRNA containing either no ABS ( . ), only the upstream ABS (a. ), or two ABS (a.a).
Incubation in HeLa extracts was for 0, 45, 60, and 90 min. RT-PCR assays performed with a single pair of primer allows amplification of the unspliced
control pre-mRNA, as well as mRNA products derived from both the control and the 7-AdA derivatives.
DOI: 10.1371/journal.pbio.0040021.g003
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hnRNP A/B and F/H Proteins Aid in Splicing5B, lane 6). However, when both the upstream and the
downstream FBS were present, splicing was strongly stimu-
lated (Figure 5B, lane 8).
To further explore the ability of FBS to mimic ABS, FBS
were inserted into a model pre-mRNA to monitor the impact
of FBS on 59 splice-site selection. We used the 553 pre-mRNA
which contains the 59 splice sites of hnRNP A1 exons 7 and 7B
joined to the downstream adenovirus 39 splice site [7].
Inserting one FBS immediately downstream of exon 7 or exon
7B only slightly stimulated distal 59 splice-site selection (553f-
and 553-f; Figure 5C, lanes 1–3). In contrast, the presence of
FBS at both positions promoted a strong increase in distal 59
splice-site usage (553ff; Figure 5C, lane 4), thereby duplicating
the impact of ABS in 59 splice-site selection [7]. Thus, the FBS
elements functioned cooperatively in vitro to stimulate distal
59 splice-site selection and splicing of an enlarged intron.
The contribution of hnRNP F/H proteins in the activity of
the FBS element was conﬁrmed in various ways. First, a gel-
shift assay indicated that recombinant hnRNP H protein, but
Figure 5. Binding Sites for hnRNP F/H Proteins Stimulate the Splicing of
an Enlarged Intron and Modulate 59 Splice-Site Selection
(A) Structure of the pre-mRNA containing the enlarged intron (lambda
insert B). The FBS was as described previously [29]. The first 6 nt of the
FBS are derived from a NcoI site used for cloning purposes.
(B) The control 7B-Ad pre-mRNA (8.7 pM) and the 7-AdB pre-mRNAs (85
pM) containing either no FBS ( . ), two FBS at the upstream position
(ff. ), one FBS at the downstream position ( .f), or FBS at both positions
(ff.f) were co-incubated for the times indicated (in hours) in a HeLa
nuclear extract. A RT-PCR assay was performed to amplify simultaneously
spliced mRNAs derived from 7B-Ad or the 7-AdB derivatives.
(C) Activity of FBS in 59 splice-site selection. The structure of the pre-
mRNA containing an FBS at one or both positions is shown on the right.
The pre-mRNAs were incubated in a HeLa extract for 2 h. A RT-PCR assay
was performed to amplify splicing products from splicing mixtures. M
indicates molecular-weight markers. The position of the products
generated from the use of the distal (D) and proximal (P) 59 splice sites,
as well as from the pre-mRNAs (Pre), is shown. The distal–proximal ratio
of products (D/P) is indicated below the lane number.
DOI: 10.1371/journal.pbio.0040021.g005
Figure 4. The In Vivo Splicing of a Large Intron Is Improved by ABS-
Containing Oligonucleotides
(A) Structure of the p44:v3kkkkkk pre-mRNA. This pre-mRNA contains
the alternatively spliced V3 exon as well as constitutive exons 5 and 16
from the CD44 gene. Six 1-kb lambda DNA repeats (gray circles) were
inserted downstream of V3 to increase the length of this intron [2]. The
position and structure of the RNA oligonucleotides are depicted. A1
indicates an ABS element.
(B) COS-7 cells were transfected with plasmid p44:V3kkkkkk. Twenty-
four hours later, they were treated with different 29O-Me RNA
oligonucleotides, and total RNA was extracted after 24 h. A RT-PCR
assay was performed in the presence of (
32P)dCTP to determine the
relative levels of both mRNA splicing products. The inclusion frequency
of exon V3 expressed as a percentage is shown graphically with mean
value and error bars derived from three separate experiments.
DOI: 10.1371/journal.pbio.0040021.g004
Figure 6. Role of hnRNP F/H Proteins in the Activity of FBS
(A) hnRNP H binds FBS specifically. The binding of hnRNP H and hnRNP A1 to FBS and ABS was monitored using a gel-shift assay. The sequence of the
FBS RNA corresponds to the sequence shown in Figure 4A, while 2XABS is a 29O-Me oligonucleotide that contains two UAGAGU elements
(CCUUUAGAGUAGUAGAGUAGAAUAAG-CCUUGCAUAAAUGG). Binding conditions were as described previously [43] and used 1.25, 2.5, and 3 lMo f
hnRNP H or A1 proteins.
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(B) hnRNP F/H are required for the activity of FBS on 59 splice-site selection. Nuclear extracts were prepared from HeLa cells that were treated with
siRNAs against hnRNP F/H [34]. Pre-mRNA substrates lacking or containing FBS were assayed in extracts prepared from mock-treated and siF/H-treated
cells. The siF/H extract was also supplemented with recombinant His-tagged hnRNP H protein prepared from baculovirus-infected cells (0.15 lM). The
ratio of the products resulting from the use of the distal or proximal 59 splice site is indicated below the lane number. The right panel shows a Western
blot analysis of the content of hnRNP F and H proteins in extracts prepared from mock-treated and siF/H-treated cells. In addition to the anti-F or anti-H
antibody, an anti-A1 antibody [45] was co-incubated to reveal A1 and monitor total protein loading.
(C) Splicing assays using the 553 and the 553ff pre-mRNAs were performed in triplicate in extracts prepared from mock-treated and siF/H-treated HeLa
cells. The ratio of the amplified products corresponding to the proximal and distal 59 splice-site usage was calculated and plotted in a graph that
displays error bars.
(D) Oligonucleotide-mediated RNase H protection assays to monitor U1 snRNP occupancy on the competing 59 splice sites. Pre-mRNAs lacking or
containing FBS or ABS were incubated at 0 8C in mock-treated and U1 snRNP-inactivated extracts (DU1). Oligonucleotides complementary to the 59
splice sites were added along with RNase H. The position of the fully protected pre-mRNAs and cleaved molecules is shown.
DOI: 10.1371/journal.pbio.0040021.g006
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hnRNP A/B and F/H Proteins Aid in Splicingnot hnRNP A1, bound the FBS element (Figure 6A, lanes 1–7).
In contrast, an oligonucleotide carrying two copies of the A1-
binding motif used in ABS (UAGAGU) had more afﬁnity for
hnRNP A1 than hnRNP H (lanes 8–14). Second, the distal 59
splice-site promoting activity of FBS was dependent upon
hnRNP F/H proteins. This was shown by incubating the 553ff
pre-mRNA in a nuclear extract prepared from HeLa cells that
had been treated with siRNAs to knockdown hnRNP F/H
expression (Figure 6B, right panel). The distal–proximal ratio
of products derived from the 553ff pre-mRNA was decreased
in such an extract, whereas this ratio was minimally affected
with the 553 pre-mRNA (Figure 6B, lanes 5 and 6, and lanes 1
and 2, respectively; see also Figure 6C). Moreover, while the
addition of recombinant hnRNP H protein only had a modest
effect on 553 pre-mRNA splicing, the distal–proximal ratio of
products derived from 553ff pre-mRNA splicing was im-
proved when hnRNP H was added to the siF/H extract (Figure
6B, lanes 3–4 and 7–8, respectively). These results suggest that
the activity of the FBS in the HeLa extract requires at least
the hnRNP H protein.
We further asked whether the strong shift in 59 splice-site
selection mediated by the pair of FBS was associated with a
corresponding change in the binding of U1 snRNP to 59
splice sites. To assess U1 snRNP binding, we performed an
oligonucleotide-mediated RNase H protection assay using a
mixture of oligonucleotides complementary to the 59 splice
sites of exon 7 and exon 7B [24]. The protection proﬁle
obtained at 0 8C with the control 553 pre-mRNA indicates
two populations of U1-bound pre-mRNAs; one bound only to
the distal 59 splice site, and a less abundant population (15%)
to which U1 is bound to both the distal and the proximal 59
splice sites (Figure 6D, lane 1). For pre-mRNAs carrying ABS
or FBS, the percentage of transcripts bound by U1 at both the
distal and the proximal 59 splice sites was reduced slightly
(11% and 4%, respectively; Figure 6D, lanes 3 and 5). The
protection observed in all cases was largely U1 snRNP-
dependent (lanes 2, 4, and 6). Our results therefore indicate
that the robust improvement in distal 59 splice-site usage
mediated by FBS and ABS was not accompanied by
equivalent changes in U1 snRNP binding to the competing
59 splice sites.
Discussion
Stimulation of Splicing by Intronic Binding Sites for hnRNP
A/B and hnRNP F/H Proteins
The initial demonstration that hnRNP A1 antagonized the
activity of SR proteins in splice-site selection assays was
followed by many reports implicating the hnRNP A/B proteins
in the activity of exonic silencer elements. Understandably,
these ﬁndings led hnRNP A/B proteins to be regarded mostly
as negative regulators of splicing. The results presented here
suggest that the binding of hnRNP A/B proteins in introns can
also play a positive role in the generic splicing reaction. Using
model pre-mRNAs harboring artiﬁcially enlarged introns that
are spliced poorly in HeLa nuclear extracts, we have shown
that intronic high-afﬁnity ABS positioned near splice junc-
tions can stimulate in vitro splicing.
On the other hand, hnRNP F/H proteins have been
implicated in the activity of both splicing enhancers and
silencers. For example, the hnRNP F and H proteins are part
of a complex assembling on an intronic enhancer element that
promotes the neuro-speciﬁc inclusion of the N1 exon in the
src pre-mRNA [21,30]. hnRNP H also activates an SC35-bound
exonic enhancer element in the human immunodeﬁciency
virus [31], but is required for the activity of a silencer element
located in a rat b-tropomyosin alternative exon [32]. Binding
sites for hnRNP H that overlap 59 or 39 splice sites can also
repress splicing [16,29,33]. Recently, we uncovered a positive
role for hnRNP F/H proteins when bound downstream of the
Bcl-xS 59 splice site [34]. We now add to this list of activities the
observation that binding sites for hnRNP F/H located at the
ends of an enlarged intron can stimulate in vitro splicing. The
ability of FBS to replicate the activity of ABS is not limited to
the splicing of enlarged introns since FBS also promoted distal
59 splice-site utilization. This situation contrasts with a recent
report documenting a complex interplay between exonic
hnRNP A1-binding sites and an intronic GGGG motif in the
inclusion of the brain-speciﬁc GRIN1 CI exon [16]. In this case,
hnRNP H binding to a GGGG motif appears to antagonize the
silencing activity of exonic A1-binding sites. These results
suggest that hnRNP A1 and H may exhibit different roles
depending on the precise arrangement of their respective
binding sites relative to a 59 splice site.
hnRNP Proteins and the Looping-Out Model
Importantly, upstream and downstream binding sites for
hnRNP F/H or hnRNP A/B proteins apparently cooperate in
some pre-mRNAs. A pair of ABS was required to stimulate
splicing of the 7B-BclA pre-mRNA. A similar requirement
was noted for FBS to stimulate the splicing of an enlarged
intron. These results are consistent with the view that the
mechanism underlying the stimulatory activity of hnRNP A/B
and F/H proteins involves an interaction involving terminally
bound proteins, such that a portion of the intron is looped
out to bring into closer proximity distantly separated exons
(Figure 7). The situation was different when we used pre-
mRNAs carrying the adenovirus major late 39 splice site. In
this case, an ABS positioned near the 59 splice site was
sufﬁcient for stimulation. Although we cannot rule out
Figure 7. The Looping-Out Model of Action for hnRNP A/B and hnRNP F/
H Proteins
hnRNP proteins bound to high-affinity binding sites (ABS or FBS) would
self-interact to loop out intron sequences and stimulate intron definition.
A similar interaction involving ABS or FBS located in distinct introns
would loop out an alternative splice site or a cassette exon to favor
skipping and commitment between the external pair of splice sites. It
remains unknown as to whether heterotypic interactions can occur
between hnRNP A/B and hnRNP F/H proteins.
DOI: 10.1371/journal.pbio.0040021.g007
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site is bound by hnRNP A1 [28] may explain why an upstream
ABS is sufﬁcient for stimulating splicing of pre-mRNAs
carrying this 39 splice site. Cooperation was also not observed
when we targeted the enlarged intron of ﬂanking CD44 exon
V3 in vivo. In this case, we noted that each of the six 977-nt
lambda inserts contain a putative ABS (UAGGGU) at position
666. Thus, we propose that an internal ABS may cooperate
with a terminal trans-acting ABS to stimulate intron removal.
The activity of ABS and FBS that is documented here is
relevant to the reported activity of GGG motifs that are
found more abundantly near the ends of introns [15]. Such
motifs have been associated with an ability to modulate 59
splice-site selection and facilitate intron splicing [13,15,17–
19]. All binding sites for hnRNP F/H proteins characterized so
far contain GGG, but it remains unclear as to whether all
GGG motifs are bound by hnRNP F/H proteins, since U1
snRNP and SF1 have also been proposed to bind to GGG
motifs [18,35]. We tested hnRNP A1, F, and H binding to the
two G-rich elements that improve splicing of a Fugu intron in
mammalian cells [15]. As judged by gel-shift analysis, the two
GGG motifs in G1 are not bound by F, H, or A1, whereas the
G2 element, which contains a G triple and a GGGG, is bound
strongly by hnRNP H but not by either hnRNP F or hnRNP
A1 (Figure S2). Although the winner high-afﬁnity site for A1
contains GGG [20], the A1-binding site that we used
(UAGAGU) lacks a G triplet and is not bound by hnRNP H.
Thus, many GGG motifs found near the ends of introns may
be binding sites for hnRNP A/B and F/H proteins, and they
may contribute to intron deﬁnition.
According to the simplest version of the looping-out
model, hnRNP A/B or F/H proteins bound near the ends of
introns would interact with one another to loop out most of
the intron. It is possible, however, that proteins bound to
terminal ABS or FBS also interact with proteins bound to
internal sites to loop out portions of the intron. In this case,
terminal ABS may ensure a maximal effect on intron
deﬁnition. To examine the generality of the potential
importance of terminal ABS and FBS, we performed a
computational analysis for the presence of intronic ABS and
FBS at the ends of 156,525 human introns of sizes  330 nt
(Table 1). Consistent with previous studies, we ﬁnd that
introns carrying one or more GGG motifs near the 59 splice
site (from positions þ11 to þ150, relative to the 59 splice
junction) or near the 39 splice site (from positions  41 to
 180, relative to the 39 splice junction) are signiﬁcantly
overrepresented when compared to the values obtained if the
sequence in these regions is randomly shufﬂed (Table 1, sh).
Next, we asked whether there was a similar enrichment for
introns carrying GGG motifs at both ends of the same intron.
Interestingly, 8,8531 introns carried at least one GGG at both
ends, a number signiﬁcantly above the predicted number
(82,606) based on the actual number of introns with GGG
motifs at either the 59 or the 39 end (Table 1, pr). To
discriminate between FBS and ABS, we repeated the analysis
using the GGGG motif as an FBS, and the AGGG
U/A motif as
an ABS. Notably, 30,501 introns carried at least one GGGG
motif at both extremities, representing an excess of 8,232
introns relative to the number predicted if occurrences at
each end were unlinked. A slightly less important enrichment
was observed when the analysis was performed with the ABS
motif. In this case, 16,523 introns contained at least one ABS
motif at both ends, representing an excess of more than 2,518
introns. As a control, we carried out the analysis with the
sequence ACAC. Introns carrying this motif at one or both
ends were not signiﬁcantly overrepresented (Table 1). Thus,
our results are consistent with the view that ABS and FBS
present at both ends of introns cooperate to function in
splicing. We noted that there was no bias in the conﬁguration
of these motifs according to intron length (data not shown),
suggesting that cooperative interactions involving terminal
ABS or FBS may occur in a large fraction of introns
irrespective of their sizes.
Thelooping-outmodelisalsothesimplestwaytoexplainthe
behavior of ABS and FBS in 59 splice-site selection. A pair of
FBS was considerably more active than individual FBS at
shifting splicing towards the distal 59 splice site (Figure 5C).
Such cooperation was not observed for ABS since distal 59
splice-site usage was signiﬁcantly stimulated by positioning an
ABS downtream of either the proximal or the distal 59 splice
site [7]. Because this pre-mRNA contains the same adenovirus
39 splice site as the one used in large-intron substrates, a
Table 1. Overrepresentation of Human Introns Carrying FBS or ABS at Both Ends
Position Intron Intronic Motifs Near Splice Sites
GGG GGGG (FBS) AGGG
U/A (ABS) ACAC
Total 59ss 116,207 (74%) 64,382 (41%) 48,413 (31%) 45,683 (29%)
sh 104,675 6 219 (67%) 50,721 6 178 (32%) 32,115 6 171 (21%) 44,046 6 201 (28%)
Total 39ss 111,467 (71%) 54,268 (35%) 45,343 (29%) 45,820 (29%)
sh 101,032 6 209 (65%) 43,842 6 176 (28%) 31,897 6 169 (20%) 46,333 6 185 (29%)
Neither 17,382 (11%) 68,376 (44%) 79,292 (51%) 79,096 (51%)
sh 23,914 6 128 (15%) 81,799 6 149 (52%) 99,889 6 182 (64%) 79,614 6 198 (51%)
Both ends 88,531 (57%) 30,501 (19%) 16,523 (11%) 14,074 (9%)
sh 73,096 6 161 (47%) 19,837 6 117 (13%) 7,376 6 82 (5%) 13,468 6 120 (9%)
pr 82,606 (53%) 22,269 (14%) 14,005 (9%) 13,337 (9%)
The presence of GGG, GGGG (FBS), AGGG
U/A (ABS), and ACAC motifs in 158,987 human introns was compiled from positionsþ11 toþ150 (relative to the 59 splice site) and 41 to 180 (relative to the 39 splice site). The number of introns (and
relative percentage) containing at least one motif at the upstream or the downstream position (59ss and 39ss, respectively), no motif at either position (Neither), or motifs at the two positions (Both ends) is indicated in black. Shuffled portions
were used to calculate how many introns (sh) carried motifs at similar positions based on random occurrence (numbers in red represent mean values with standard deviations). The predicted (pr) set given for introns carrying motifs at both
ends (in blue) was calculated from the actual fraction of introns carrying motifs at individual ends. If p5 is the fraction of introns having a 59 motif and p3 is the fraction of introns having a 39 motif, then the ‘‘predicted’’ number of introns
having both (assuming independence of the occurrences on both ends) would be p3 3 p5.
DOI: 10.1371/journal.pbio.0040021.t001
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to explain this apparent lack of cooperation. Thus, appropri-
ately positioned ABS or FBS can promote alternative 59 splice-
site usage and, possibly, exon skipping (Figure 7). Consistent
with this view, we have shown that deleting the intronic ABS
ﬂanking constitutive exon 7 and/or alternative exon 7B in the
hnRNP A1 pre-mRNA promotes exon 7B inclusion [6].
Additional experimental evidence indirectly supports the
looping-out model. A1 proteins self-interact [36], and A1
molecules bound to one ABS can simultaneously interact with
another ABS [6]. As these activities require the glycine-rich
domain of hnRNP A1, it is notable that hnRNP F/H proteins
also contain glycine-rich domains, and that an interaction
between hnRNP F and H has been described [30]. The crystal
structure of UP1 bound to high-afﬁnity DNA-binding sites is
also consistent with the looping model [37]. UP1 contains the
two RNA-recognition motifs (RRMs) but lacks the C-terminal
glycine-rich domain of A1. In the co-crystal, UP1 exists as a
dimer, the RRM1 of each UP1 molecule being bound to sites
located on two distinct oligonucleotides. Although UP1 lacks
the activity of A1 in splicing and does not self-interact in
biochemical and two-hybrid assays [36], the very high
concentration of proteins used to promote crystal formation
may have forced UP1 dimerization. Thus, we envision that A1
proteins individually bound to distinct high-afﬁnity sites may
interact through their glycine-rich domains. This A1–A1
interaction would bring into close proximity the two RNA
regions, and the RRM2 domains of each A1 molecule may
subsequently cross-interact with sequences ﬂanking the other
ABS to stabilize the complex. We speculate that the RRM2
domain of A1 may engage in this type of interaction because
the RRM1 is sufﬁcient for speciﬁc binding to one high-afﬁnity
site [38]. Finally, we have shown that providing FBS or ABS
near the ends of an enlarged intron is functionally equivalent
to having inverted repeats at these positions. Duplex-forming
elements are present in many yeast introns to facilitate
commitment between pairs of splice sites [39–42]. It is
intriguing to consider that interactions between hnRNP
proteins, rather than duplex formation, may have been
selected to help in deﬁning mammalian introns. However, it
is possible that, in some situations, base-pairing interactions
between sequences ﬂanking individual ABS or FBS may
further stabilize the conformational changes initiated by
hnRNP proteins.
According to the looping-out model, the interaction
between hnRNP A/B or between F/H proteins bound in the
intron near splice junctions would represent a key step
leading to efﬁcient formation of a commitment complex. In
vitro, the splicing efﬁciency of a small intron was not affected
by ABS or by variations in the concentration of A1, possibly
because the splice-site pairing step is not rate-limiting.
Although the presence of ABS and FBS improved the splicing
efﬁciency of enlarged introns in vitro, the activity of these
elements may be more important in vivo when splicing
decisions are taken co-transcriptionally. The hnRNP A/B or F/
H–mediated looping out of intron sequences as they exit
from the RNA polymerase II transcription complex may
facilitate intron deﬁnition by improving the frequency of an
encounter between a U1-bound 59 splice site and a U2AF-
bound 39 splice site located downstream from the ABS–ABS
or FBS–FBS complex.
The looping out of an intron may also occur in several
steps, as would be expected when additional ABS or FBS are
distributed along an intron. Given that a 59 splice site located
in between two ABS is repressed [7], the ABS- or FBS-
mediated looping out of portions of introns may neutralize a
multitude of weaker and/or non-productive interactions with
pseudo or cryptic splice sites. However, if a splice site located
between hnRNP-binding sites is strong enough, its commit-
ment to an upstream 59 splice site or to a downstream 39
splice site may kinetically out-compete the looping-out
process mediated by hnRNP proteins. The relative frequency
of the two events would be expected to contribute towards
setting alternative splicing proﬁles, and hence, may be
inﬂuenced by the position of the splice sites relative to ABS
or FBS, the speed of transcription, and the presence of
silencers/enhancers ﬂanking alternative splice sites.
Finally, the mechanism by which a looped-out splice site is
repressed by ﬂanking ABS or FBS remains unclear. The
binding of U1 snRNP to a 59 splice site is not greatly affected
by ﬂanking ABS or FBS. However, this mechanism of
repression may be similar to the mechanism by which
inverted repeats repress 59 splice-site usage when substituted
for ABS or FBS [7]. Commitment, or a later step of
spliceosome assembly, may be compromised or delayed by a
relatively rigid complex (ABS–ABS, FBS–FBS, or a duplex
structure) whose topology may be incompatible with the
structural ﬂexibility necessary for efﬁcient spliceosome
assembly.
We are currently investigating whether heterotypic inter-
actions can take place between hnRNP A/B and hnRNP F/H
proteins as well as between other glycine-rich RNA-binding
proteins. If so, such interactions may also play a role in
remodeling the conformation of mammalian pre-mRNAs,
with a signiﬁcant impact on splicing efﬁciency and splice-site
selection.
Materials and Methods
Oligonucleotides. T h eD N Ap r i m e r su s e df o rt h eR T - P C R
ampliﬁcation of spliced products were 20 nt in length. E-Ad and
BclX3 were used as downstream primers for the RT step and the PCR
ampliﬁcation of products carrying the adenovirus or Bcl-x as second
exon, respectively. E-Ad (59-GAGTTTGTCCTCAACCGCGA-39)i s
complementary to the 59 end of the adenovirus exon L2. BclX3 (59-
TCGGCTGCTGCATTGTTCCC-39) is complementary to a region in
Bcl-x exon 3. The upstream primer in all ampliﬁcations from in vitro
splicing assays was a 21-nt oligonucleotide T3–59 (59-GGGAA-
CAAAAGCTGGGTACCG-39) that hybridizes near the 59 end of all
transcripts synthesized from the T3 RNA polymerase promoter.
Custom-made RNA oligonucleotides were purchased from Dhar-
macon Research (Lafayette, Colorado, United States). The 39 half of
the upstream oligonucleotide UA or UB is complementary to the
intronic sequences at the 59 end of the lambda insert A or B,
respectively, 42 nt downstream from the 59 splice site. These
oligonucleotides have a CE1a element sequence at the 59-end portion.
Oligonucleotide UOA contains the same complementary sequences,
but the CE1a element is located at the 39 end. The downstream
oligonucleotides Da and Db are complementary to a 20-nt region 67
nt upstream of the adenovirus exon L2, and 122 nt upstream of the
Bcl-x exon 3, respectively. These oligonucleotides contain the CE1a
element at their 39-end portion. Oligonucleotide UBn shares its last
19 nt with oligonucleotide UB but has a non-ABS 25-nt tail at its 59
end. Oligonucleotide UST has a 20-nt region at the 39 end
complementary to the intronic sequences between the distal and
the proximal 59 splice sites in RNA 553 [7], while the 59 portion of this
oligonucleotide contains the CE1a element.
29O-Me oligonucleotides used in transfection assays include
UV3A1, which is complementary to a 20-nt region starting 20 nt
downstream from the 59 splice site of exon V3. UV3A1 has the ABS
from the CE1a element [43]. UV3NT contains the same complemen-
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and UV3A1W5, respectively, contain two, three, and ﬁve consecutive
ABS derived from the winner binding site for hnRNP A1 [20]. D16A1
and D16A1W, respectively, contain the CE1a and the winner A1-
binding sites. mA1W5 carries ﬁve ABS but is complementary to the
pre-mRNA of hnRNP A1. The sequences of all oligonucleotides used
in splicing are shown in Table 2.
Transcription and splicing assays. Constructs containing the
adenovirus exon L2 were linearized with ScaI, whereas constructs
containing Bcl-x exon 3 were linearized using BglII and used as
templates for in vitro transcription. In general, pre-mRNA substrates
were synthesized in vitro using T3 RNA polymerase (USB) in the
presence of minimal amounts of
32P-UTP and gel-puriﬁed as
described previously [7]. A known amount of the pre-mRNA was
then incubated in HeLa nuclear extract [44] under standard splicing
conditions [24] at 30 8C. The RNA material was then extracted with
phenol-chloroform-isoamylalcohol (PCA) and ethanol precipitated.
To investigate the effect of RNA oligonucleotides on splicing, pre-
mRNA molecules were mixed with either the individual oligonucleo-
tide or with a mixture of the oligonucleotides prior to splicing. RNA
species obtained after splicing were quantitated and resuspended in
sterile water to a concentration of 5–10 atomoles per ll. An
equivalent amount of this solution was then subjected to RT-PCR
ampliﬁcation. To analyze pre-mRNA splicing on conventional
denaturing acrylamide gels, uniformly labeled pre-mRNAs were
synthesized and processed as described previously [7].
The treatment of HeLa cells with siRNA to knockdown hnRNP F/H
was performed as described previously [34]. Western blot analysis was
performed using antibodies against hnRNP F and hnRNP H (kindly
provided by Douglas Black). Recombinant His-tagged hnRNP F and
hnRNP H proteins were produced from baculovirus-infected cells as
described previously [34].
RT-PCR. The pre-mRNAs incubated in splicing extracts were
minimally labeled such that the amount of pre-mRNA used could be
precisely quantitated and followed until after PCA extraction and
ethanol precipitation. In many experiments, a small-intron pre-
mRNA was co-incubated with the test pre-mRNA in splicing mixtures
to assess equivalent recovery and loading. In some experiments, RNA
controls were added only before the RT-PCR reaction. Ampliﬁcation
protocols used the ready-to-go RT-PCR beads (Amersham Pharmacia
Biotech, Piscataway, New Jersey, United States) as described
previously [7]. In several experiments, ampliﬁcations were performed
in the presence of
32P-labeled dCTP. The reaction mixtures after
ampliﬁcation were treated with RNase A and the products were
resolved on a 5% non-denaturing acrylamide gel, unless stated
otherwise. The gel was stained with ethidium bromide and photo-
graphed under UV light. When ampliﬁed products were
32P-labeled,
products were quantiﬁed on an InstantImager (Canberra-Packard,
Meriden, Connecticut, United States) or a Storm PhosphorImager
(Amersham Biosciences, Little Chalfont, United Kingdom) and then
exposed on ﬁlm.
Immunoprecipitation assay. Plasmids p7-AdA( . ) and (a.a) were
linearized with BsmAI and transcribed with T3 RNA polymerase to
generate uniformly labeled RNA. Brieﬂy, splicing reactions contain-
ing 10
5 counts per minute of
32P-labeled transcripts were incubated
in a HeLa nuclear extract for 30 min at 30 8C, either in the presence
or in the absence of oligonucleotides. Reactions were then placed on
ice and incubated for 30 min with 1 ll of an antibody against hnRNP
A1/A2 [45]. A quantity (50 ll) of protein A Sepharose (5 mg,
Amersham Pharmacia Biotech) was added and the mixture was
incubated for 15 min. After three washes with 1 ml of NET-2 buffer
(50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.5 mM DTT; and 0.05%
Nonidet P-40), samples were PCA extracted and ethanol precipitated.
The RNA recovered was fractionated on a denaturing 5% poly-
acrylamide gel.
Gel shift and RNase H protection assays. The gel-shift assay with
recombinant hnRNP proteins was carried out as described previously
[43]. DU1 HeLa extracts were produced by addition of the 29O-Me
oligonucleotide CCUGCCAGGUAAGUA complementary to the 59
end of U1 snRNA [46]. The oligonucleotide-mediated RNase H
protection assay was conducted as described previously [24].
Transfection and RNA analysis. COS-7 cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium, supplemented with 10% fetal
bovine serum. Twenty-four hours prior to plasmid transfections, cells
were seeded in six-well plates (35 mm) at a density of 2.5 3 10
5 cells/
well. At 50% conﬂuence, the cells were transiently transfected with 2
lg of the puriﬁed plasmid p44:V3kkkkkk [2] using Lipofectamine
Plus (Invitrogen, Carlsbad, California, United States). Twenty-four
hours later, the cells were treated with different 29O-Me RNA
oligonucleotides to a ﬁnal concentration of 50 nM, and the cell
culture was continued for 24 h.
Total RNA was prepared using TRIzol (Invitrogen) and treated
with DNase I, according to the manufacturer’s indications. Reverse
transcription was performed with Omniscript RT (Qiagen, Valencia,
California, United States) and the RT3 primer (GAAGGCACAGTC-
GAGGCTG), which anneals to the 39-UTR of the pcDNA3 vector to
avoid the interference of the endogenous CD44 mRNA. The reaction
was carried out at 37 8C for 60 min, stopped at 95 8C for 5 min and
ice-quenched, followed by PCR ampliﬁcation in the presence of
(a-
32P)dCTP and of oligonucleotide primers directed to CD44 exons 5
and 16 (AGTGAAAGGAGCAGCACTTCAGG and TCAGATCCAT-
GAGTGGTATGGGAC, respectively). The ampliﬁcation procedure
was as follows: 95 8C for 5 min, 35 cycles at 94 8C for 30 sec, 56 8C for
30 sec, and 72 8C for 30 sec; with a ﬁnal extension at 72 8C for 15 min.
Reaction products were resolved by electrophoresis in a non-
Table 2. Sequence of the Antisense 29O-Me RNA Oligonucleotides




















The antisense portions are underlined and the A1/A2–binding sites are in bold. The non-ABS extensions of UBn, USn, and UAn are shown in lowercase letters.
DOI: 10.1371/journal.pbio.0040021.t002
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tImager system (Canberra-Packard).
Computational analysis. Human introns were from National
Center for Biotechnology Information (NCBI) human genome build
35.1 (http://www.ncbi.nlm.nih.gov). A total of 156,525 introns of sizes
greater than 330 bp were retained for further analysis. One hundred
rounds of shufﬂing were carried out in selected portions (þ11 toþ150
and  41 to  180) of all introns to calculate random occurrence and
standard deviations.
Supporting Information
Figure S1. RT-PCR Assay of Splicing Mixtures Incubated with
Different Ratios of Test and Control Pre-mRNAs
A quantity (80 pM) of test 7-AdA( . ) or 7-AdA (þ.þ) pre-mRNA was
mixed with various amounts of control 7B-Ad pre-mRNA (from 0 to
40 pM). The mixtures were incubated in HeLa nuclear extracts for 2 h
at 30 8C. The RT-PCR assay was carried out with a single pair of
primers that amplify mRNA products derived from all pre-mRNAs.
The stimulation provided by ABS can be observed at all ratios of test
and control pre-mRNAs.
Found at DOI: 10.1371/journal.pbio.0040021.sg001 (201 KB EPS).
Figure S2. Gel-Shift Assay Using Recombinant hnRNP H, F, and A1
The initial G1 and G2 elements (larger letters) stimulated splicing
when inserted into a Fugu intron. The sequences immediately
ﬂanking the insertion sites are also shown. The 16-nt G1 and 19-nt
G2 RNA oligonucleotides were 59-end labeled and individually
incubated with hnRNP proteins (1, 2, and 3 lM) in the presence of
heparin. Complexes were fractionated on a native 5% acrylamide gel.
Found at DOI: 10.1371/journal.pbio.0040021.sg002 (431 KB EPS).
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